14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AXSM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Axsome Therapeutics stock price up 0.88% on Tuesday
(Updated on Apr 16, 2024)

Sell candidate since Mar 28, 2024 Loss -13.77% PDF

The Axsome Therapeutics stock price gained 0.88% on the last trading day (Tuesday, 16th Apr 2024), rising from $68.21 to $68.81. During the last trading day the stock fluctuated 4.40% from a day low at $67.10 to a day high of $70.05. The price has fallen in 6 of the last 10 days and is down by -7.71% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 34 thousand more shares were traded than the day before. In total, 457 thousand shares were bought and sold for approximately $31.48 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.57% during the next 3 months and, with a 90% probability hold a price between $45.73 and $61.23 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Check out how to make money doing surveys! Ad

AXSM Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 0.88%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Axsome Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $70.52 and $75.00. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Axsome Therapeutics stock

Axsome Therapeutics finds support from accumulated volume at $68.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.95 between high and low, or 4.40%. For the last week, the stock has had daily average volatility of 4.00%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AXSM) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Axsome Therapeutics to open at $68.65, and during the day (based on 14 day Average True Range), to move between $65.64 and $71.98, which gives a possible trading interval of +/-$3.17 (+/-4.60%) up or down from last closing price. If Axsome Therapeutics takes out the full calculated possible swing range there will be an estimated 9.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $68.21 (0.87%) than the resistance at $75.54 (9.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Axsome Therapeutics stock A Buy?

Axsome Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.460 Sell Candidate Unchanged

Predicted Opening Price for Axsome Therapeutics of Wednesday, April 17, 2024

Fair opening price April 17, 2024 Current price
$68.65 ( 0.228%) $68.81

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AXSM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 71.60 4.06 %
R2 70.48 2.42 %
R1 69.78 1.41 %
Current price: 68.81
Support S1 67.53 -1.87 %
S2 66.83 -2.88 %
S3 65.70 -4.51 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 82.11 19.33 %
R2 81.14 17.92 %
R1 75.54 9.78 %
Current price 68.81
Support S1 68.21 -0.87%
S2 0 .
S3 0 .

FAQ

What is the symbol for Axsome Therapeutics Stock and on which exchange is it traded?
The symbol for Axsome Therapeutics is AXSM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Axsome Therapeutics Stock?
Axsome Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Axsome Therapeutics Stock?
Axsome Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Axsome Therapeutics Stock.

What's the current price of Axsome Therapeutics Stock?
As of the end of day on the 2024-04-16, the price of an Axsome Therapeutics (AXSM) share was $68.81.

What is the 52-week high and low for Axsome Therapeutics Stock?
The 52-week high for Axsome Therapeutics Stock is $98.40 and the 52-week low is $55.03.

What is the market capitalization of Axsome Therapeutics Stock?
As of the 2024-04-16, the market capitalization of Axsome Therapeutics is 3.231B.

When is the next earnings date for Axsome Therapeutics?
The upcoming earnings date for Axsome Therapeutics is May 06, 2024.
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT